D
Journey Medical Corporation DERM
$7.42 $0.020.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1,136.54% -99.64% -280.79% -48.45% 102.15%
Total Depreciation and Amortization 20.24% 4.61% -9.11% -23.52% -27.01%
Total Amortization of Deferred Charges 118.28% -13.72% -13.76% -41.89% -43.47%
Total Other Non-Cash Items 7.11% -20.66% -15.77% -37.23% -50.45%
Change in Net Operating Assets 81.70% -45.25% -127.55% -201.58% -196.28%
Cash from Operations 66.04% -689.63% -274.18% -255.50% 1.69%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -200.00% 100.00% 100.00%
Cash from Investing -- -- -200.00% 100.00% 100.00%
Total Debt Issued -75.00% -33.33% -76.74% -39.55% -47.37%
Total Debt Repaid 82.95% 92.19% 97.59% 98.88% 76.09%
Issuance of Common Stock 75.35% 73.99% 79.70% 26,456.00% 18,370.59%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 86.84% 89.38% 89.38% -317.58% -317.58%
Cash from Financing -5.46% 688.79% 453.73% 210.92% 284.93%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -152.21% -46.28% -56.31% 77.44% 132.76%